Also, in the 4T1 breast cancer model the combination of systemic IFNα with topical IMQ inhibited the growth of primary tumors (Fig. 2g) and protected mice from the development of lung metastases (Fig. 2h,i). This evidence concerns the gene IFNA2 and breast cancer.